Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Retained Earnings (2016 - 2025)

Marimed (MRMD) has disclosed Retained Earnings for 15 consecutive years, with -$123.3 million as the latest value for Q3 2025.

  • On a quarterly basis, Retained Earnings fell 18.66% to -$123.3 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$123.3 million, a 18.66% decrease, with the full-year FY2024 number at -$113.4 million, down 13.5% from a year prior.
  • Retained Earnings was -$123.3 million for Q3 2025 at Marimed, down from -$118.8 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of -$83.9 million in Q4 2022 to a low of -$123.3 million in Q3 2025.
  • A 5-year average of -$98.9 million and a median of -$97.4 million in 2021 define the central range for Retained Earnings.
  • Peak YoY movement for Retained Earnings: grew 16.42% in 2021, then dropped 20.32% in 2024.
  • Marimed's Retained Earnings stood at -$97.4 million in 2021, then grew by 13.83% to -$83.9 million in 2022, then fell by 19.1% to -$100.0 million in 2023, then dropped by 13.5% to -$113.4 million in 2024, then decreased by 8.69% to -$123.3 million in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Retained Earnings are -$123.3 million (Q3 2025), -$118.8 million (Q2 2025), and -$117.6 million (Q1 2025).